| Immediate effects of lumacaftor/ivacaftor administration on lung function in patients with severe cystic fibrosis lung disease N Popowicz, J Wood, A Tai, S Morey, S Mulrennan Journal of Cystic Fibrosis 16 (3), 392-394, 2017 | 40 | 2017 |
| Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis LJ Sherrard, AS Tai, BA Wee, KA Ramsay, TJ Kidd, NL Ben Zakour, ... PLoS One 12 (3), e0172179, 2017 | 39 | 2017 |
| Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis … BA Wee, AS Tai, LJ Sherrard, NL Ben Zakour, KR Hanks, TJ Kidd, ... BMC genomics 19, 1-11, 2018 | 25 | 2018 |
| Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis AS Tai, SC Bell, TJ Kidd, E Trembizki, C Buckley, KA Ramsay, M David, ... PLoS One 10 (12), e0144022, 2015 | 24 | 2015 |
| Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation A Vaitekenas, AS Tai, JP Ramsay, SM Stick, A Kicic Antibiotics 10 (2), 145, 2021 | 20 | 2021 |
| Overcoming challenges to make bacteriophage therapy standard clinical treatment practice for cystic fibrosis RN Ng, AS Tai, BJ Chang, SM Stick, A Kicic Frontiers in Microbiology 11, 593988, 2021 | 18 | 2021 |
| Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis AS Tai, LJ Sherrard, TJ Kidd, KA Ramsay, C Buckley, M Syrmis, ... BMC pulmonary medicine 17, 1-10, 2017 | 14 | 2017 |
| Clostridium difficile infection in cystic fibrosis: an uncommon but life‐threatening complication F Piccolo, AS Tai, H Ee, S Mulrennan, S Bell, G Ryan Respirology Case Reports 5 (1), e00204, 2017 | 13 | 2017 |
| Molecular surveillance for carbapenemase genes in carbapenem resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis AS Tai, TJ Kidd, DM Whiley, KA Ramsay, C Buckley, SC Bell, ... Pathology 47 (2), 156-160, 2015 | 13 | 2015 |
| Why we still need drugs for COVID‐19 and can't just rely on vaccines BWS Robinson, A Tai, K Springer Respirology (Carlton, Vic.) 27 (2), 109, 2022 | 11 | 2022 |
| Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis M Boyle, S Mulrennan, S Morey, S Vekaria, N Popowicz, A Tai Respirology Case Reports 9 (1), e00696, 2021 | 10 | 2021 |
| Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis AS Tai, P Putsathit, L Eng, K Imwattana, DA Collins, S Mulrennan, ... Journal of Hospital Infection 113, 44-51, 2021 | 8 | 2021 |
| Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis AS Tai, HE Sidjabat, TJ Kidd, DM Whiley, DL Paterson, SC Bell Journal of microbiological methods 111, 105-107, 2015 | 6 | 2015 |
| Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosa RN Ng, LJ Grey, A Vaitekenas, SA McLean, JD Rudrum, DR Laucirica, ... Journal of Microbiological Methods 190, 106346, 2021 | 5 | 2021 |
| Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians G Currie, A Tai, T Snelling, A Schultz BMJ Open Respiratory Research 8 (1), e000956, 2021 | 4 | 2021 |
| 669 Beatson SA, Bell SC. 2017. Within-host whole genome analysis of an antibiotic resistant 670 Pseudomonas aeruginosa strain sub-type in cystic fibrosis LJ Sherrard, AS Tai, BA Wee, KA Ramsay, TJ Kidd, NL Ben Zakour, ... PLoS One 12, e0172179, 0 | 4 | |
| Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm‐forming multidrug‐resistant cystic fibrosis‐associated Pseudomonas aeruginosa as a … RR Haines, P Putsathit, AS Tai, KA Hammer Letters in Applied Microbiology 75 (3), 578-587, 2022 | 3 | 2022 |
| Complete genome sequences of four Pseudomonas aeruginosa bacteriophages: Kara-mokiny 8, Kara-mokiny 13, Kara-mokiny 16, and Boorn-mokiny 1 A Vaitekenas, AS Tai, JP Ramsay, SM Stick, P Agudelo-Romero, A Kicic, ... Microbiology Resource Announcements 11 (12), e00960-22, 2022 | 2 | 2022 |
| Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa RR Haines, P Putsathit, KA Hammer, AS Tai Scientific Reports 12 (1), 16814, 2022 | 2 | 2022 |
| The open door policy-An important and under-recognised activity of the adult CF centre AS Tai, S Morey Journal of Cystic Fibrosis 17 (5), 558-559, 2018 | 1 | 2018 |
